178 related articles for article (PubMed ID: 7853514)
1. V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate.
Kim FM; Kolson DL; Balliet JW; Srinivasan A; Collman RG
J Virol; 1995 Mar; 69(3):1755-61. PubMed ID: 7853514
[TBL] [Abstract][Full Text] [Related]
2. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.
Smyth RJ; Yi Y; Singh A; Collman RG
J Virol; 1998 May; 72(5):4478-84. PubMed ID: 9557745
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.
Chesebro B; Wehrly K; Nishio J; Perryman S
J Virol; 1992 Nov; 66(11):6547-54. PubMed ID: 1404602
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
[TBL] [Abstract][Full Text] [Related]
5. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
[TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
Willey RL; Theodore TS; Martin MA
J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
[TBL] [Abstract][Full Text] [Related]
7. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
Lusso P; Cocchi F; Balotta C; Markham PD; Louie A; Farci P; Pal R; Gallo RC; Reitz MS
J Virol; 1995 Jun; 69(6):3712-20. PubMed ID: 7745720
[TBL] [Abstract][Full Text] [Related]
8. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop.
Donaldson YK; Bell JE; Holmes EC; Hughes ES; Brown HK; Simmonds P
J Virol; 1994 Sep; 68(9):5991-6005. PubMed ID: 7545945
[TBL] [Abstract][Full Text] [Related]
9. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
Westervelt P; Trowbridge DB; Epstein LG; Blumberg BM; Li Y; Hahn BH; Shaw GM; Price RW; Ratner L
J Virol; 1992 Apr; 66(4):2577-82. PubMed ID: 1548783
[TBL] [Abstract][Full Text] [Related]
10. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells.
Carrillo A; Ratner L
J Virol; 1996 Feb; 70(2):1310-6. PubMed ID: 8551601
[TBL] [Abstract][Full Text] [Related]
11. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.
Shioda T; Levy JA; Cheng-Mayer C
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9434-8. PubMed ID: 1409653
[TBL] [Abstract][Full Text] [Related]
12. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.
Collman R; Balliet JW; Gregory SA; Friedman H; Kolson DL; Nathanson N; Srinivasan A
J Virol; 1992 Dec; 66(12):7517-21. PubMed ID: 1433527
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.
Mammano F; Salvatori F; Ometto L; Panozzo M; Chieco-Bianchi L; De Rossi A
J Virol; 1995 Jan; 69(1):82-92. PubMed ID: 7527089
[TBL] [Abstract][Full Text] [Related]
14. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
Gu R; Westervelt P; Ratner L
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
[TBL] [Abstract][Full Text] [Related]
15. Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA.
Ebenbichler C; McNearney T; Stoiber H; Möst J; Zangerle R; Vogetseder W; Patsch JR; Ratner L; Dierich MP
Mol Immunol; 1995 Oct; 32(14-15):1039-45. PubMed ID: 8544853
[TBL] [Abstract][Full Text] [Related]
16. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
[TBL] [Abstract][Full Text] [Related]
17. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
[TBL] [Abstract][Full Text] [Related]
18. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
Koito A; Harrowe G; Levy JA; Cheng-Mayer C
J Virol; 1994 Apr; 68(4):2253-9. PubMed ID: 8139010
[TBL] [Abstract][Full Text] [Related]
19. Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages.
Malykh A; Reitz MS; Louie A; Hall L; Lori F
Virology; 1995 Jan; 206(1):646-50. PubMed ID: 7831820
[TBL] [Abstract][Full Text] [Related]
20. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
